Wednesday, December 02, 2020 Congratulations from CCTG! The Canadian Cancer Society (CCS) has funded its first research grant focused specifically on rare and aggressive uterine cancers, a critical first step to better outcomes for people with these cancers to Dr Stephanie Lheureux. “Uterine carcinosarcoma is a rare but very aggressive type of cancer, with few effective treatment options,” says Dr Stephanie Lheureux, a medical oncologist and researcher who received the 2-year, $180,000 research grant. “My team and I are studying this rare uterine cancer with the hope that we can improve survival and quality of life for our future patients and their loved ones.” With CCS support, Dr Lheureux and her team are embarking on an ambitious project to delve into the biology of uterine carcinosarcoma and better understand its origins. These cancers are often diagnosed late and do not respond to existing therapies, making them very difficult to treat. Because uterine carcinosarcomas are rare, very little is known about how they grow and why they resist conventional treatments. Find out more.
